NYT > Health: InterMune Lung Drug Is Successful In New Trial

InterMune Lung Drug Is Successful In New Trial

The company said it would apply for United States regulatory approval of pirfenidone to treat idiopathic pulmonary fibrosis, a scarring of the lungs.

Source: http://www.nytimes.com/2014/02/26/business/intermune-reports-successful-trial-for-lung-disease-drug.html?partner=rss&emc=rss